Cargando…

Vitamin K antagonist has a higher impact than heparin in preventing circuit clotting in chronic haemodialysis patients

BACKGROUND: In dialysis sessions, some data suggest that decreasing or even avoiding additional anticoagulation by heparin is possible among patients already treated with oral anticoagulation. However, the required dose of heparin may actually depend on the pre-dialysis international normalized rati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Charles, Pierre-Yves, Le Meur, Yannick, Tanquerel, Tugdual, Galinat, Hubert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467595/ https://www.ncbi.nlm.nih.gov/pubmed/32905339 http://dx.doi.org/10.1093/ckj/sfz131

Ejemplares similares

POS-961 INCREASED RISK OF EXTRACORPOREAL CIRCUIT CLOTTING IN HAEMODIALYSIS PATIENTS WITH COVID 19
por: Sudusinghe, D.H., et al.
Publicado: (2022)

Can we accurately predict where we look at paintings?
por: Le Meur, Olivier, et al.
Publicado: (2020)

Low-molecular weight heparin infusion as anticoagulation for haemodialysis
por: Wong, Steve Siu-Man, et al.
Publicado: (2016)

Heparin-coated vs. Non-coated Cardiopulmonary Bypass Circuits: Comparing Immediate Results with Different Target Activated Clotting Time
por: Hanedan, Muhammet Onur, et al.
Publicado: (2020)

An Antithrombin-Heparin Complex Increases the Anticoagulant Activity of Fibrin Clots
por: Smith, Lesley J., et al.
Publicado: (2008)

Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation
por: Lau, Yee Cheng, et al.
Publicado: (2016)

Bovine and porcine heparins: different drugs with similar effects on human haemodialysis
por: Tovar, Ana MF, et al.
Publicado: (2013)

Quality improvement project to enhance heparin safety in patients with haemodialysis in China
por: Tan, Qiu-zhen, et al.
Publicado: (2022)

EFFECT OF HEPARIN AND BIVALIRUDIN ON THE KINETICS OF CLOT FORMATION: VISCOELASTIC COAGULATION TESTING
por: Hasija, Suruchi, et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa
por: Parasrampuria, Dolly A., et al.
Publicado: (2015)

Effect of anticoagulants on fibrin clot structure: A comparison between vitamin K antagonists and factor Xa inhibitors
por: Gauer, Julia S., et al.
Publicado: (2020)

Strategies for asymmetrical triacetate dialyser heparin-free effective haemodialysis: the SAFE study
por: Vandenbosch, Ines, et al.
Publicado: (2020)

Heparin-free regional anticoagulation of haemodialysis filters with calcium-free dialysate: is citrate mandatory?
por: Medrano, Chloé, et al.
Publicado: (2021)

Modulation of fibrin clot formation by human serum amyloid P component (SAP) and heparin
Publicado: (1983)

Comparison of digoxin concentration in plastic serum tubes with clot activator and heparinized plasma tubes
por: Dukić, Lora, et al.
Publicado: (2014)

A Blinded Randomized Trial Comparing Standard Activated Clotting Time Heparin Management to High Target Active Clotting Time and Individualized Hepcon HMS Heparin Management in Cardiopulmonary Bypass Cardiac Surgical Patients
por: Nuttall, Gregory A., et al.
Publicado: (2021)

Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial
por: Ezekowitz, Michael D, et al.
Publicado: (2018)

Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
por: Kumano, Osamu, et al.
Publicado: (2021)

PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients
por: O'Toole, Robert V, et al.
Publicado: (2021)

Causes of Vitamin K Deficiency in Patients on Haemodialysis
por: Wikstrøm, Signe, et al.
Publicado: (2020)

Novel Antagonists of Heparin Binding Growth Factors
por: Cecchi, Fabiola, et al.
Publicado: (2012)

Exertional Desaturation Has Higher Mortality Than Non-Desaturation in COPD
por: Liu, Shih-Feng, et al.
Publicado: (2021)

Renal unit practitioners’ knowledge, attitudes and practice regarding the safety of unfractionated heparin for chronic haemodialysis
por: Ockhuis, Debra, et al.
Publicado: (2015)

Different type and dosage of heparin were not associated with the progression of coronary artery calcification in haemodialysis patients
por: Niu, Qingyu, et al.
Publicado: (2019)

How plausible is transmission of hepatitis C virus via the haemodialysis circuit?
por: Meyrier, A., et al.
Publicado: (2011)

Dialysis circuit clotting in critically ill patients with COVID-19 infection
por: Khoo, Benjamin Zhi En, et al.
Publicado: (2021)

Clot waveform of APTT has abnormal patterns in subjects with COVID-19
por: Shimura, Takuya, et al.
Publicado: (2021)

FLOWERING LOCUS T has higher protein mobility than TWIN SISTER OF FT
por: Jin, Suhyun, et al.
Publicado: (2015)

Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia
por: Poli, Maura, et al.
Publicado: (2017)

To Clot or Not to Clot: Is That the Question?
por: Favaloro, Emmanuel J.
Publicado: (2023)

Anti-PF4/heparin antibodies associated with repeated hemofiltration-filter clotting: a retrospective study
por: Lasocki, Sigismond, et al.
Publicado: (2008)

Use of activated clotting time to monitor anticoagulation in patients receiving unfractionated heparin on renal replacement therapy
por: Bidwai, A, et al.
Publicado: (2011)

Short‐Term Risk of Bleeding During Heparin Bridging at Initiation of Vitamin K Antagonist Therapy in More Than 90 000 Patients With Nonvalvular Atrial Fibrillation Managed in Outpatient Care
por: Bouillon, Kim, et al.
Publicado: (2016)

Heparin requirements for full anticoagulation are higher for patients on dabigatran than for those on warfarin – a model-based study
por: Edrich, Thomas, et al.
Publicado: (2015)

Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
por: Yamaji, Hirosuke, et al.
Publicado: (2016)

Successful treatment of calciphylaxis with vitamin K in a patient on haemodialysis
por: Wajih, Zainab, et al.
Publicado: (2021)

Hereditary combined deficiency of the vitamin K-dependent clotting factors
por: Napolitano, Mariasanta, et al.
Publicado: (2010)

The effect of citrate dialysate on intradialytic heparin dose in haemodialysis patients: study design of a randomised controlled trial
por: Tai, Davina J., et al.
Publicado: (2015)

Argatroban caused severe hypercholesterolaemia in a chronic haemodialysis patient with heparin-induced thrombocytopenia: an unreported adverse effect?
por: Nakagawa, Tetsuya
Publicado: (2008)

Electrochemical Polymerization of PEDOT–Graphene Oxide–Heparin Composite Coating for Anti-Fouling and Anti-Clotting of Cardiovascular Stents
por: Yang, Ming-Chien, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nnlknkcm4cbqmd6fa8aco0qk6n